AYUSH 64 found useful in the treatment of mild to moderate COVID-19 infection
NEW DELHI: In the middle of the havoc wreaked by second wave of the pandemic, AYUSH-64 has emerged as a...
NEW DELHI: In the middle of the havoc wreaked by second wave of the pandemic, AYUSH-64 has emerged as a...
NEW DELHI: Serum Institute of India (SII) -- the maker of the most used COVID-19 vaccine in the country --...
NEW DELHI: India has declined assistance offered by the United Nations (UN) of its integrated supply chain for COVID19-related material,...
NEW DELHI: India, despite severe constraints and within its own limited resources, has tried to "walk the talk" on vaccine...
NEW DELHI: India saw a record single day rise of 3,79,257 new coronavirus infections pushing the total tally of COVID-19...
WASHINGTON: Covaxin, India's home-grown COVID-19 vaccine, has been found to neutralise the 617 variant of the deadly virus, White House...